Search results
Results from the WOW.Com Content Network
Pages in category "Biotechnology companies of India" The following 18 pages are in this category, out of 18 total. This list may not reflect recent changes. A.
The first Indian biotechnology company to be established was Biocon, which was founded by Kiran Mazumdar-Shaw in 1978. [3] The Indian biotechnology industry formally began in 1986 with the establishment of the Department of Biotechnology (DBT) by the Ministry of Science and Technology. [4]
Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India. [5] As of July 2020, the company has over 700 employees [6] and has a presence worldwide. [5] The company has been responsible for developing an eco-friendly recombinant [7] and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Shantha Biotechnics Limited is an Indian biotechnology company headquartered in Hyderabad, India. It is the first Indian company to develop, manufacture and market recombinant human healthcare products in India. The company is a wholly owned subsidiary of Sanofi group. [1]
Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune It is the world's largest manufacturer of vaccines by volume. [ 5 ] [ 6 ] [ 7 ] It was founded by Cyrus Poonawalla in 1966 [ 5 ] and is a part of Cyrus Poonawalla Group.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India.It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
During the COVID-19 pandemic, the company signed a pact with Baylor College of Medicine, Texas Children's Hospital and Dynavax Technologies to develop a COVID-19 vaccine. [6] [7] The vaccine Corbevax [8] /Bio E COVID-19 was expected to roll out in 2021 with 75 to 80 million doses manufactured per month; the production was expected to reach 1 billion doses by the end of 2022 under the Quad ...